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CASE REPORT
Multifactorial aetiology for non-uremic calciphylaxis: a case report
Sijan Basnet a, Niranjan Tachamoa, Rashmi Dhital a and Biswaraj Tharu b
aDepartment of Medicine, Reading Hospital and Medical Center, West Reading, PA, USA; bMaharajgunj Medical Campus, Tribhuvan
University, Kathmandu, Nepal
ABSTRACT
Calciphylaxis is commonly associated with end-stage renal disease patients on haemodialysis.
We present a rare case of calciphylaxis in a non-uremic patient. The diagnosis was made
clinically and confirmed with skin biopsy showing calcification of the dermal and subcuta-
neous tissues in the von Kossa stain. We believe that the combination of uncontrolled
diabetes mellitus, a non-functioning paraganglioma and vitamin D deficiency in a susceptible
female patient was responsible for causing calciphylaxis in our patient. An index of suspicion
should be maintained by clinicians for calciphylaxis even in patients without uremia.
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1. Introduction
Calciphylaxis, also known as calcific uremic arterio-
pathy, is characterized by medial calcification of
superficial blood vessels with skin and soft tissue
necrosis [1–4]. It affects up to 4% patients on hae-
modialysis and has a mortality rate of 45–80% with
ulcerated lesions [1,5–7]. Of late, it is being reported
in patients without end-stage renal disease [8]. It has
been associated with primary hyperparathyroidism,
malignancy, alcoholic liver disease, proteins C and S
deficiencies, connective tissue disorders, vitamin D
deficiency, Crohn’s disease, obesity, and medications
(calcium, warfarin and corticosteroids) [7–9]. We
present a case of a 70-year-old woman diagnosed
with non-uremic calciphylaxis.
2. Case description
A 71-year-old female presented to the emergency
department (ED) with left leg pain, swelling and
fever for 1 day. It was preceded by recent unroofing
of the nail bed of the great toe. She had poorly
controlled type II diabetes mellitus, hypertension
and coronary artery disease. In the ED, she was
febrile (temperature 103.1°F) with blood pressure of
188/120 mm Hg and pulse of 106/min. Physical
examination revealed barely palpable peripheral
pulses. The left leg appeared bluish and was extre-
mely tender. White blood cell count on admission
was 19,500/µl with neutrophilia. Ultrasound of left
lower extremity (LLE) was negative for deep vein
thrombosis. She was septic on presentation and was
started on vancomycin, cefepime and metronidazole.
CT scan of LLE showed diffuse cellulitis/oedema
without abscess or osteomyelitis. She underwent
LLE arterial duplex which did not show any hemo-
dynamically significant stenosis. The ankle-brachial
index showed moderate arterial insufficiency but no
evidence of rest pain or critical limb ischemia. On day
3 of presentation, three patches and a bulla appeared
on the left leg. Cutaneous vasculitis was suspected.
ANA, ANCA, serum C3, C4, Rheumatoid factor,
homocysteine, hypercoagulability panel, lipid panel,
hepatitis B and hepatitis C were unremarkable. A
transesophageal echocardiogram done to rule out
septic emboli from infective endocarditis was nega-
tive for vegetation. A punch biopsy done from the
posteromedial aspect of the left leg showed superficial
and deep inflammation with areas of superficial epi-
dermal necrosis and was diagnosed as livedoid vascu-
litis. Cultures of the skin biopsy were negative. The
diagnosis was met with scepticism and the slides were
sent to a dermatopathologist. The patient was dis-
charged on wound care and pain control with a
review pending.
The patient again presented to the ED a week
later with substernal exertional chest pain.
Workup for acute coronary syndrome was nega-
tive but a significant drop in haemoglobin from
12.3 to 8.4 g/dl was noted since prior admission.
The patient underwent upper gastrointestinal
endoscopy which showed a sessile 7 mm nodule
on the anterior wall of the bulb of the duodenum
which was biopsied using cold forceps. Biopsy of
the nodule in duodenum showed nests of tumour
cells which were positive for chromogranin,
synaptophysin, CD56 and pankeratin, consistent
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with a neuroendocrine tumour. With plasma
metanephrines and MIBG whole body scan being
normal, there was low suspicion that it was a
functional paraganglioma. By this time, the ulcera-
tions were necrotic and had progressed to the left
medial leg (Figure 1). Punch biopsies were again
taken. Hematoxylin and eosin stained sections
reveal an epidermal ulceration, areas of necrosis,
neutrophilic inflammatory infiltrate with karyor-
rhexis in the dermis and subcutaneous tissue.
Focal areas of lipomembranous, fibrinized vessels
and focal basophilic stippling of the subcutaneous
vessels were noted (Figure 2). Paraganglioma as
aetiology of calciphylaxis was thought to be unli-
kely as it was nonfunctional. A von Kossa stain
showed calcium deposition in the small vessels of
the subcutaneous tissue consistent with a diagno-
sis of calciphylaxis. A Gram stain, GMS stain,
AFB-Fite stain and cultures failed to show an
infection.
Workup for an aetiology is detailed in Table 1.
Given that the mechanism of her diagnosed calciphy-
laxis was unclear, sodium thiosulfate was not started.
The patient was discharged with recommendations to
Figure 1. Ulceration and necrosis of the left lower extremity overlying calciphylaxis.
Figure 2. Skin biopsy of necrosed area. Focal areas of lipomembranous, fibrinized vessels and focal basophilic stippling of the
subcutaneous vessels.
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follow-up with wound care. A year later, the patient
has still been following with wound care for poor
healing LLE ulcer.
3. Discussion
With the majority of calciphylaxis seen in the setting
of end-stage renal disease, it is believed to result from
secondary hyperparathyroidism and elevation of the
serum calcium-phosphate product [1]. This does not
explain other reported cases of calciphylaxis that lack
this association. Thus a multifactorial aetiology is
likely [1,10]. End-stage renal disease, secondary
hyperparathyroidism, hypercalcemia and hyperpho-
sphatemia are proposed metabolic derangements
which result in precipitation of calcium-phosphate
in the presence of metallic salts such as iron and
aluminium, egg albumin, trauma, etc. [1,9,11,12].
This precipitated product calcify the medium and
small vessels and occlude them with resulting ische-
mia [1,2,9–11]. In our patient, her uncontrolled dia-
betes mellitus and history of vitamin D deficiency are
possible precipitating factors for calciphylaxis. We
have low suspicion that her duodenal paraganglioma
as it was nonfunctional.
Patients often present with deep dermal pain and
palpable masses. The skin lesions are initially violaceous
that progress to livedo reticularis and eventually form
eschar with non-healing ulcers within days to few weeks
[1,6,10]. They have a distal or sacral distribution with a
propensity for areas with abundant adipose tissue [2,13].
Calciphylaxis is a clinical diagnosis and does not
require skin biopsy for confirmation [11].
Histologically, calciphylaxis features acute and
chronic inflammation with calcified blood vessels
and necrosis in the dermal and subcutaneous tissues.
The classic appearance of the fully evolved disease
features a patchy, relatively ‘clean’ necrosis with scant
acute and chronic inflammation and a background of
calcified small and medium-sized blood vessels in the
dermis and subcutis[1]. Calcification is best seen
under von Kossa or Alizarin red stains [1,7]. A
bone scan can also aid in the detection of calcification
in soft tissues [8,10].
Various treatment options, although available,
have little benefit [7,10]. Supportive management
like pain control and wound care with sodium thio-
sulfate, hyperbaric oxygen therapy, tissue plasmino-
gen activator, vitamins D and K supplementation,
parathyroidectomy, and daily haemodialysis have
been described in literature [5,14,15]. Sodium thio-
sulfate is thought to work by enhancing the solubility
of calcium phosphate and removing calcifications
[5,10,15]. It also prevents precipitation of calcium
deposits [10].
4. Conclusion
Calciphylaxis in a non-uremic patient is a rare diagnosis
but has a poor prognosis similar to a patient with ESRD
[1]. Physicians should be aware of this condition so that
early diagnosis and treatment may be instituted.
Table 1. Potential contributing factors of calciphylaxis.
Serial
number Contributing factors Workup on our patient
1. End-stage kidney disease CKD stage 2 with baseline creatinine: 0.80–1.00 mg/dl and GFR 65–85 ml/min/1.73 sq. m.
2. Primary hyperparathyroidism Serum PTH: 48 (reference range: 12–88 pg/ml). Normal calcium, phosphorous with initial vitamin D
deficiency.
3. Malignancy Diagnosed with duodenal paraganglioma during endoscopy.
No history of cholangiocarcinoma, chronic myelocytic leukemia, malignant melanoma, metastatic
breast cancer or multiple myeloma.
4. Alcoholic liver disease History of occasional alcohol use. CT abdomen showed normal liver. AST: 24 IU/L, ALT: 7 IU/L
6. Hypoalbuminemia (malnutrition
and weight loss)
Serum albumin was 2.8 g/dL on presentation. 2 months prior to presentation was normal (3.7 g/dL)
7. Connective tissue diseases Rheumatoid arthritis: Denied joint pain, swelling or morning stiffness. Rheumatoid factor: 11.0
(reference range: ≤14.0 IU/ml)
Systemic lupus erythematosus: ANA negative. Didn’t meet criteria for SLE
Giant cell arteritis: Denied visual disturbances, headache, jaw claudication and scalp tenderness. ESR
110 (reference range for age: 40 mm/hr) elevated from possible inflammation.
8. Diabetes mellitus Poorly controlled type II diabetes mellitus on insulin. HbA1c: 10.2% (reference range: 4.9–6%)
9. Protein C and S deficiency No history of chemotherapy.
Protein C activity: 94 (reference range: 70–130%)
Protein S activity: 56 (reference range: 55–123%)
10. Crohn’s disease Normal bowel habits. Colonoscopy a few years ago showed hyperplastic polyp with normal colonic
mucosa.
12. Vitamin D deficiency History of Vitamin D deficiency.
Vitamin D total: 26 (reference range: 25−80 ng/ml)
Vitamin D 25 hydroxy: 17.9 (reference range: deficient <20 ng/ml) on initially. 2 weeks later, level was
34.7 on subsequent presentation.
Normal calcium, phosphorus, and PTH.
13. Calcium supplementation No history of calcium supplementation
14. Weight loss and obesity No weight changes; BMI: 26 kg/m2.
15. Warfarin necrosis No history of warfarin use.
16. Corticosteroids No history of steroids use.
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